Alzheon

Developer of disease-modifying treatments for Alzheimer's disease and other neurodegenerative disorders

placeFramingham, Massachusetts, United States calendar_todayFounded 2013 groups22 employees language alzheon.com

Registered entities

Innovation

13 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 626 times.

YearFilings
20151
20161
20173
20185
20194
20207
20216
20226
20239
20249
202510
20263

Social engagement

Social engagement: 6.5K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Alerce Medical Technology Partners, Ally Bridge Group.

Investor typeCountShare
Venture capital233%
Private equity233%
Other / undisclosed233%

Recent activity

25 Jun 2026
Milestone
anniversary
15 Jun 2026
Event
6th International Conference of the Trisomy 21 Research Society
13 May 2026
Event
BcnPit XIV Biennial Conference
Coming soon